Investment ThemesDetailed Quotes
Gene Editing
Watchlist
Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1412.441
- -28.979-2.01%
Close Feb 27 16:00 ET
1449.332High1411.102Low
1419.441Open1441.420Pre Close25.75MVolume1RiseLossP/E (Static)1.17BTurnover--Flatline2.06%Turnover Ratio168.94BMarket Cap9Fall166.76BFloat Cap
Constituent Stocks: 10Top Rising: NTLA+0.56%
Rise too fast and fall too fast...!
Insiders loading up! Is there something big coming?🤔
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
Friday, 21st February at 7:30 am
bluebird stockholders to receive $3.00 per share in cash and a contingent value right of $6.84 per share in cash payable upon achievement of a net sales milestone, contingent upon offer conditions
bluebird's Board of Directors determined this transaction is in the best interest of stockholders following a comprehensive review of strategic alternatives
...
Can bluebird bio Hit $600M Sales Target? What the $9.84 Per Share Buyout Really Means
No comment yet